Canaccord raised the firm’s price target on ASP Isotopes (ASPI) to $11 from $8.50 and keeps a Buy rating on the shares. The firm said they are positive on the multiple definitive agreements with TerraPower, “related to financing support for the construction of a new uranium enrichment facility capable of producing High Assay Low-Enriched Uranium (HALEU), and the future supply of HALEU to TerraPower, as a customer.” Canaccord raised its estimates and they see room for further upside with the announced transaction and management’s ability to execute.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASPI:
- Home Depot backs outlook as U.S. sales ticked up: Morning Buzz
- ASP Isotopes enters agreement relating to potential Renergen acquisition
- ASP Isotopes enters loan agreement, supply agreements with TerraPower
- ASP Isotopes Inc options imply 6.0% move in share price post-earnings
- ASP Isotopes Inc options imply 11.3% move in share price post-earnings
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue